MEN Type 2 (MEN2) Syndromes

Source: Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 3, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Childhood Multiple Endocrine Neoplasia (MEN) Syndromes

The management of medullary thyroid cancer in children from families with MEN2 syndromes relies on presymptomatic detection of the RET proto-oncogene variant responsible for the disease.

Continue within this section

MEN2A syndrome →MEN2B syndrome →Targeted therapy →

Preserved source evidence · Not medical advice